Latest 20-F annual reports

Sportradar Group AG announced robust financial results for the fiscal year ended December 31, 2025, with significant revenue and profit growth, alongside the strategic acquisition of IMG Arena.

PRF Technologies reports significant losses and a going concern warning, pivoting its drug development to OcuRing-K while expanding its DeepSolar AI analytics business.

Borr Drilling Limited reported a decrease in net income and operating income for 2025, alongside strategic fleet acquisitions and management changes, while navigating industry volatility and significant debt maturities.

Nexa Resources S.A. reported a net income of $223.1 million in 2025, reversing a net loss from the prior year, driven by higher metal prices despite decreased mining and smelting production volumes.

YPF reports increased operating profit and robust unconventional production growth in 2025, despite a net loss driven by income tax adjustments and ongoing macroeconomic challenges in Argentina.

Inspira Technologies, a medical device company, reported a net loss of $13.2 million for 2025, its first revenue of $289,000 from ART100 sales, and faces going concern doubts while advancing its life-support technologies.

Austin Gold Corp. reported a net loss of $1.62 million for 2025, a significant reduction from previous years, as it continues to advance exploration on its key gold projects in Nevada and Oregon.

Global-E Online Ltd. reported significant financial improvements in 2025, achieving GAAP net profit and robust growth in GMV and revenue, driven by platform expansion and strategic partnerships.

Eltek Ltd. reported an 80% drop in net income for 2025, driven by increased costs, production inefficiencies, and adverse currency fluctuations, despite an 11% revenue increase.

Quantum BioPharma Ltd. reports a net loss of $26.96 million for 2025, driven by R&D costs and significant cryptocurrency fair value adjustments, while advancing its MS drug and settling key litigation.

Galapagos NV announced a significant strategic shift, winding down its cell therapy operations and small molecule discovery programs to focus on business development-led pipeline expansion in oncology and immunology, backed by a strong cash position.

Nyxoah SA achieved FDA approval for its Genio system in August 2025, driving significant revenue growth in 2025, despite continued operating losses and ongoing concerns about its ability to continue as a going concern.

Evogene Ltd. reported a strategic shift to focus on its ChemPass AI platform for small molecule discovery in pharma and agriculture, alongside significant operating losses and a going concern warning for 2025.

Can-Fite BioPharma Ltd. reported a net loss of $9.8 million for 2025, continuing its history of operating losses, while advancing its clinical pipeline and securing additional capital.

Freightos Limited reported a 24% revenue increase and a reduced net loss in 2025, driven by its solutions segment and a strategic focus on software adoption to fuel platform growth.

Allot Ltd. reported a net income of $3.7 million in 2025, a significant turnaround from a $5.9 million net loss in 2024, driven by increased revenues and improved gross margins.

CollPlant Biotechnologies reports a $11.5 million net loss for 2025, driven by R&D investments and cost-cutting, while advancing rhCollagen-based products and securing new funding.

ParaZero Technologies Ltd. reports a strategic shift towards defense and homeland security markets, achieving revenue growth in 2025 while continuing to incur net losses and raising significant capital.

Golar LNG Limited reports significant financial growth in 2025, driven by the FLNG Gimi's commercial operations and new long-term contracts for FLNG Hilli and MKII FLNG, alongside a strategic review for future value.

Ferroglobe PLC posted a substantial net loss of $177.1 million in 2025, a sharp reversal from the prior year's profit, driven by declining sales and challenging market conditions.

Prudential plc delivered double-digit growth across key financial metrics in 2025, increasing dividends by 15% and committing to over $7 billion in capital returns to shareholders by 2027.

AngloGold Ashanti plc reported a significant increase in profit and gold production for 2025, driven by higher gold prices and strategic portfolio optimization.

Aegon Ltd. announced its intention to relocate its head office and legal seat to the United States, renaming the holding company Transamerica Inc. upon completion, while reporting strong 2025 financial results and outlining future growth ambitions.

Brookfield Wealth Solutions reports a decrease in net income for 2025, primarily due to fair value movements, but strong growth in distributable operating earnings and total assets driven by strategic acquisitions and investment strategies.

JBS N.V. has filed its annual report on Form 20-F with the SEC, detailing its financial performance, operational segments, risk factors, and corporate governance for the fiscal year ended December 31, 2025.

Polyrizon Ltd. reported a significant increase in net loss to $3.3 million in 2025, driven by expanded research and development activities and administrative costs, while securing substantial capital for future operations.

Marex Group plc reported substantial financial growth in 2025, driven by strategic acquisitions and increased client activity across its diversified global commodity and financial markets platform.

COSCIENS Biopharma Inc. reported a significant net loss for 2025, driven by declining revenues and strategic restructuring, including the wind-down of its biopharmaceutical segment and German subsidiaries.

Banco Bradesco S.A. reports a significant 36.4% increase in net income for 2025, driven by higher net interest income and fee growth, alongside strategic acquisitions and ongoing digital transformation.

Horizon Quantum Holdings Ltd. has successfully completed its business combination and commenced trading on Nasdaq, securing significant capital for its quantum computing software development.